AMT is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of autoimmune diseases.
Business Model:
Revenue: $0
Employees: 51-200
Address: 1 Tower Place
City: South San Francisco
State: CA
Zip: 94080
Country: US
AMT is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of autoimmune diseases.
Contact Phone:
+16503920420
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/4/2020
Ticker Symbol:
AMTI
IPO Price:
$14/share
Amount Raised:
$154M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2021 | Post-IPO Equity | 1 | $105M |
KG Investments KG Investments |
10/2019 | Series C | 2 | $41.9M |
Founders Fund EPIQ Capital Group Founders Fund EPIQ Capital Group |
10/2018 | Series B | 2 | $31M |
EPIQ Capital Group Founders Fund EPIQ Capital Group Founders Fund |
6/2020 | IPO | $154M |
|
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|